Loading paragraph...
Today's Biggest Stock Losers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| TIL | Instil Bio | $6.66 | -$5.63 | -45.81% | 2.5M | $83M | $5.67$42.79 |
| FOFO | Hang Feng Technology Innovation | $6.51 | -$2.61 | -28.62% | 465.3K | - | $4.63$68.00 |
| BGL | Blue Gold | $2.11 | -$0.58 | -21.56% | 563.6K | $84M | $1.83$166.50 |
| RKLZ | Tidal Trust II - Defiance Daily Target 2x Short Rklb ETF | $3.18 | -$0.81 | -20.30% | 16.8M | - | $3.16$25.51 |
| BNR | Burning Rock Biotech | $19.55 | -$4.93 | -20.14% | 94.8K | $221M | $2.18$24.92 |
| SLS | Sellas Life Sciences Group | $4.10 | -$0.90 | -18.00% | 26.8M | $712M | $0.85$5.18 |
| SOFX | Tidal Trust II - Defiance Daily Target 2x Long Sofi ETF | $29.81 | -$5.48 | -15.53% | 1.9M | - | $4.59$49.53 |
| GANX | Gain Therapeutics | $2.55 | -$0.42 | -14.14% | 3.2M | $114M | $1.41$4.34 |
| ZKH | Zkh Group | $3.18 | -$0.50 | -13.59% | 864K | $479M | $2.50$3.90 |
| ATRA | Atara Biotherapeutics | $14.57 | -$2.29 | -13.58% | 227.4K | $122M | $5.01$19.15 |
Related Articles
Featured Article
A Deal With Novo Nordisk Sent This Stock 181% Higher Overnight. Is It a Buy Now?
Cory Renauer|Oct 16, 2025
Find out if the deal Omeros announced is enough of a reason to buy this stock.
Up More Than 500% in 2024. Can Instil Bio Keep Rocketing Higher?
Cory Renauer|Sep 14, 2024
A candidate that Instil Bio in-licensed this August is similar to a candidate that recently outperformed the world's top-selling cancer therapy.
Should Growth Investors Buy This Revolutionary Small-Cap Stock?
Kody Kester|Jul 25, 2023
The medical devices company is taking an exciting approach to treating some of the most complex diseases.
Advertisement
Wall Street Thinks This Small-Cap Stock Can Double in Value
Kody Kester|Apr 4, 2023
Analysts are projecting a huge rebound from this beaten-down stock in the next 12 months.
Is This Under-the-Radar Growth Stock a Buy?
Kody Kester|Jan 19, 2023
This company is a small player in the steadily growing medtech industry.
Wall Street Thinks This Obscure Growth Stock Could Soar 92% in 2023
Kody Kester|Dec 30, 2022
As COVID-19 headwinds fade, AngioDynamics' business could rebound.
Here's Why This Hidden Growth Stock Is a Buy
Kody Kester|Oct 21, 2022
This medical device company may not be a household name, but it could be an up-and-comer.
Why This New EV Stock Won't Be the Next Tesla
Rich Duprey|Oct 4, 2022
Electric motorcycles are just not a big enough market to compete against EVs.
Should You Buy This Under-the-Radar Growth Stock?
Kody Kester|Jul 29, 2022
Like the Nasdaq Composite, this little-known medical device stock has been beaten down in 2022.
3 Reasons to Consider Buying This Overlooked Medical Device Stock
Kody Kester|May 1, 2022
The Nasdaq's sell-off looks to have given investors a buying opportunity in this little-known medical device stock.
